Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
D000110:Acetylcholinesterase / Q000378:metabolism; D000284:Administration, Oral; D000374:Aggression / Q000187:drug effects; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects; D002188:Cannabis / Q000494:pharmacology*; D002389:Catatonia / Q000139:chemically induced; D003864:Depression, Chemical; D013759:Dronabinol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D008297:Male; D009419:Nerve Tissue Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D051381:Rats; D012640:Seizures / Q000139:chemically induced; D013268:Stimulation, Chemical; D013997:Time Factors
D009419:Nerve Tissue Proteins; D012313:RNA; D013759:Dronabinol; D000110:Acetylcholinesterase